Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinfeng Luo

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
ACS Medicinal Chemistry Letters|May 20, 2017
2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) InhibitorsCheng Mo, Zhang Zhang, Christopher P Guise, et al.
Journal of Medicinal Chemistry|March 3, 2018
Design, Synthesis, and Structure-Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5- d]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase InhibitorsQiuju Xun, Zhang Zhang, Jinfeng Luo, et al.
Journal of Medicinal Chemistry|October 24, 2012
Design, synthesis, and biological evaluation of 3-(1H-1,2,3-triazol-1-yl)benzamide derivatives as Potent Pan Bcr-Abl inhibitors including the threonine(315)→isoleucine(315) mutantYupeng Li, Mengjie Shen, Zhang Zhang, et al.
European Journal of Medicinal Chemistry|November 29, 2020
Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitorsMinhao Huang, Yongjun Huang, Jing Guo, et al.
Journal of Medicinal Chemistry|February 21, 2012
Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting epidermal growth factor receptor threonine⁷⁹⁰ → methionine⁷⁹⁰ mutantShaohua Chang, Lianwen Zhang, Shilin Xu, et al.
Journal of Medicinal Chemistry|July 17, 2019
2-Amino-2,3-dihydro-1<i>H</i>-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer EfficacyDongsheng Zhu, Huocong Huang, Daniel M Pinkas, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) InhibitorsZhen Wang, Yali Zhang, Sergio G Bartual, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
N-(3-Ethynyl-2,4-difluorophenyl)sulfonamide Derivatives as Selective Raf InhibitorsYingjun Li, Huimin Cheng, Zhang Zhang, et al.
Journal of Medicinal Chemistry|June 7, 2017
Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) InhibitorsYu Chang, Xiaoyun Lu, Marthandam Asokan Shibu, et al.
European Journal of Medicinal Chemistry|May 19, 2017
2-Oxo-3, 4-dihydropyrimido[4, 5-d]pyrimidinyl derivatives as new irreversible pan fibroblast growth factor receptor (FGFR) inhibitorsXueqiang Li, Christopher P Guise, Rana Taghipouran, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
ACS Medicinal Chemistry Letters|May 20, 2017
2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) InhibitorsCheng Mo, Zhang Zhang, Christopher P Guise, et al.
Journal of Medicinal Chemistry|March 3, 2018
Design, Synthesis, and Structure-Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5- d]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase InhibitorsQiuju Xun, Zhang Zhang, Jinfeng Luo, et al.
Journal of Medicinal Chemistry|October 24, 2012
Design, synthesis, and biological evaluation of 3-(1H-1,2,3-triazol-1-yl)benzamide derivatives as Potent Pan Bcr-Abl inhibitors including the threonine(315)→isoleucine(315) mutantYupeng Li, Mengjie Shen, Zhang Zhang, et al.
European Journal of Medicinal Chemistry|November 29, 2020
Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitorsMinhao Huang, Yongjun Huang, Jing Guo, et al.
Journal of Medicinal Chemistry|February 21, 2012
Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting epidermal growth factor receptor threonine⁷⁹⁰ → methionine⁷⁹⁰ mutantShaohua Chang, Lianwen Zhang, Shilin Xu, et al.
Journal of Medicinal Chemistry|July 17, 2019
2-Amino-2,3-dihydro-1<i>H</i>-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer EfficacyDongsheng Zhu, Huocong Huang, Daniel M Pinkas, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) InhibitorsZhen Wang, Yali Zhang, Sergio G Bartual, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
N-(3-Ethynyl-2,4-difluorophenyl)sulfonamide Derivatives as Selective Raf InhibitorsYingjun Li, Huimin Cheng, Zhang Zhang, et al.
Journal of Medicinal Chemistry|June 7, 2017
Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) InhibitorsYu Chang, Xiaoyun Lu, Marthandam Asokan Shibu, et al.
European Journal of Medicinal Chemistry|May 19, 2017
2-Oxo-3, 4-dihydropyrimido[4, 5-d]pyrimidinyl derivatives as new irreversible pan fibroblast growth factor receptor (FGFR) inhibitorsXueqiang Li, Christopher P Guise, Rana Taghipouran, et al.
Pageof 6